Impaired wound healing is associated with hyperglycaemia in patients with diabetes. Hyperglycaemia induces protein glycation and the formation of Advanced Glycation End-Products (AGEs). The accumulation of AGEs in the body results in the structural and functional modification of tissue proteins. This study was conducted to evaluate compounds with antiglycation activities (S-Ally1 Cysteine (SAC), N-Acetylcysteine (NAC) and the mimic compound A). The extent of glycation in the presence and absence of several inhibitors was assessed via several methods including fluorescence, Sodium Dodecyl Sulphate-Polyacrylamide Gel Electrophoresis (SDS-PAGE)- silver stain, Western blotting, and Enzyme-Linked Immunosorbent Assays (ELISA). Additionally, this research aimed to evaluate and quantify the potential of Human Adipose Mesenchymal Stem Cells (hADMSCs) to uptake and release these drugs as potential therapeutics. To achieve this, hADMSCs were primed with a combination of SAC/NAC and mimic compound A and their concentrations were analysed using High-Performance Liquid Chromatography (HPLC). The SAC/NAC and mimic compound A prohibit the formation of AGEs while the Conditioned Medium (CM) from SAC/NACand compound A-loaded hADMSCs induced cell migration and tube formation in BAECs. hADMSCs provide a unique opportunity for the development of an innovative targeting and drug-delivery system which could effectively deliver therapeutics to specific regions of wounds or other damaged tissues. The data provided demonstrate the potential of hADMSCs as a drug delivery method with the potential to improve wound healing, and it may offer potential therapeutic targeting for the development of diabetic complications.
Solitary Fibrous Tumor of the Pleura (SFTP) is an exceptionally rare mesenchymal tumor that typically originates from the visceral pleura and constitutes less than 5% of all pleural tumors. While it often displays benign histological features, the tumor’s behavior remains enigmatic and less comprehensively understood, primarily owing to its limited incidence and case studies. We present two cases of SFTP. The First one was a small pleural nodule a nodule in a 61 year old patien, confirmed as a SFTP through CT-guided biopsy. Successful tumor resection was performed, with histopathological confirmation, and the patient remained recurrence-free for two years. The second one was incidental finding in a 68-year-old patient of a huge pleural mass with necrotic regions and microcalcifications on imaging. Surgical removal revealed an encapsulated tumor with myxoid features, classified as an intermediate-risk SFTP. The patient experienced no complications and had no local recurrence 16 months post-surgery. Solitary fibrous tumors within the pleura are uncommon. The preferred treatment approach is surgical resection, with diligent post-operative monitoring.
Background: Primary intraparenchymal meningiomas are extremely rare; their similarities to other intra-axial lesionsand thelack of dural adhesion make their presurgical diagnostic approach challenging. Case Description: A 27-year-old male, with no past medical history, presented to our emergency department for a first time grand mal seizure. Magnetic resonance imaging evidenced a 1,6×1,2 cm mass in the right temporo-parietal region. It was iso intense on T1WI, hyper intense on T2 WI, surrounded by large vasogenic edema and homogeneously enhanced on contrast magnetic resonance imaging with diffusion restriction. During surgery, the tumor was found to be located within the parenchyma with no dural attachment. It was removed en bloc. Histopathological examination confirmed the positive diagnosis of transitional meningioma (WHO Grade I). Conclusion: Intraparenchymal meningiomas are rarely reported in the literature. Their preoperative diagnosis is extremely difficult to make. Histopathological examination plays a key role for an accurate diagnosis.
Application of Deep Learning LSTM and ARIMA Models in Time Series Forecasting: A Methods Case Study analyzing Canadian and Swedish Indoor Air Pollution Data
Thrombocytopenia is a commonly encountered during course of chemotherapy. Breast cancer is the most common cancer in women worldwide. A 58 years old lady, diagnosed case of carcinoma breast left side (early stage) on adjuvant trastuzumab therapy developed progressive thrombocytopenia. The treatment was stopped and started on oral steroids. The platelet count recovered slowly on oral steroids. In this review we have highlighted a very rarely encountered side effect of trastuzumab induced thrombocytopenia.
